Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of ProQuad with Recombinant Human Albumin in Toddlers
NCT00560755Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2007
- Primary completion
- Nov 2008
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Oct 2007; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00560755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560755.